Further, Nec-1 administration suppresses Ch25h gene expression in microglia of AD mice models, leading to reduced neuroinflammation and cognitive impairments, suggesting that altered lipid metabolism might be associated with AD pathogenesis [149]. This evidence concerns the gene CH25H and Alzheimer disease.